We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
First Commonwealth Financial
FCF
$2.11B
| $1.31M | ﹤0.01% |
80,596
-43,157
| -35% | -$666K |
|
1052
Amylyx Pharmaceuticals
AMLX
$3.87B
| $1.31M | ﹤0.01% |
203,930
+1,145
| +0.6% | +$5.57K |
|
1053
Dole
DOLE
$1.3B
| $1.31M | ﹤0.01% |
93,339
-259
| -0.3% | -$3.67K |
|
1054
Johnson Controls International
JCI
$84.6B
| $1.31M | ﹤0.01% |
12,359
+6,760
| +121% | +$622K |
|
1055
Honeywell
HON
$68.9B
| $1.3M | ﹤0.01% |
5,944
-297
| -5% | -$60.1K |
|
1056
Watsco Inc
WSO
$12.8B
| $1.3M | ﹤0.01% |
2,944
-93
| -3% | -$43.1K |
|
1057
Horizon Bancorp
HBNC
$1B
| $1.3M | ﹤0.01% |
84,461
+22,935
| +37% | +$337K |
|
1058
MasTec
MTZ
$19.4B
| $1.3M | ﹤0.01% |
7,600
-1,092
| -13% | -$157K |
|
1059
Coherent
COHR
$54.7B
| $1.29M | ﹤0.01% |
14,511
-163
| -1% | -$11.7K |
|
1060
Tiptree Inc
TIPT
$687M
| $1.29M | ﹤0.01% |
54,896
+74
| +0.1% | +$1.65K |
|
1061
Park Hotels & Resorts
PK
$3.19B
| $1.28M | ﹤0.01% |
125,268
-7,074
| -5% | -$72K |
|
1062
AGNC Investment
AGNC
$12.9B
| $1.28M | ﹤0.01% |
139,356
+3,611
| +3% | +$32.3K |
|
1063
Performance Food Group
PFGC
$15.8B
| $1.27M | ﹤0.01% |
14,571
-221
| -1% | -$18.4K |
|
1064
Tapestry
TPR
$25B
| $1.27M | ﹤0.01% |
14,514
-15,822
| -52% | -$1.2M |
|
1065
Mativ Holdings
MATV
$669M
| $1.27M | ﹤0.01% |
186,304
+185,593
| +26,103% | +$1.07M |
|
1066
Hain Celestial
HAIN
$66.1M
| $1.27M | ﹤0.01% |
834,586
-224,716
| -21% | -$525K |
|
1067
Universal Insurance Holdings
UVE
$1.21B
| $1.27M | ﹤0.01% |
45,673
-29
| -0.1% | -$736 |
|
1068
IonQ
IONQ
$15.9B
| $1.26M | ﹤0.01% |
+29,364
| New | +$984K |
|
1069
Gibraltar Industries
ROCK
$1.34B
| $1.26M | ﹤0.01% |
21,347
-942
| -4% | -$53.9K |
|
1070
SiriusXM
SIRI
$9.62B
| $1.24M | ﹤0.01% |
54,122
+1,059
| +2% | +$22.8K |
|
1071
Burlington
BURL
$17.2B
| $1.23M | ﹤0.01% |
5,305
-16,762
| -76% | -$3.98M |
|
|
HTO
1072
H2O America
HTO
$2.66B
| $1.23M | ﹤0.01% |
23,662
+23,482
| +13,046% | +$1.25M |
|
1073
Rithm Capital
RITM
$5.63B
| $1.23M | ﹤0.01% |
108,638
-44,813
| -29% | -$494K |
|
1074
Lands' End
LE
$370M
| $1.23M | ﹤0.01% |
114,398
+47,955
| +72% | +$434K |
|
|
NTST
1075
NETSTREIT Corp
NTST
$2.08B
| $1.22M | ﹤0.01% |
+72,278
| New | +$1.16M |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.